In the last trading session, 2.4 million Biohaven Ltd (NYSE:BHVN) shares changed hands as the company’s beta touched 3.50. With the company’s per share price at $13.96 changed hands at -$0.15 or -1.06% during last session, the market valuation stood at $1.43B. BHVN’s last price was a discount, traded about -299.0% off its 52-week high of $55.70. The share price had its 52-week low at $13.87, which suggests the last value was 0.64% up since then. When we look at Biohaven Ltd’s average trading volume, we note the 10-day average is 2.18 million shares, with the 3-month average coming to 2.24 million.
Analysts gave the Biohaven Ltd (BHVN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.25. If we narrow down to specifics, the data shows that 0 out of 7 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended BHVN as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight.
Biohaven Ltd (NYSE:BHVN) trade information
Instantly BHVN was in red as seen at the end of in last trading. With action -5.48%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -60.22%, with the 5-day performance at -5.48% in the red. However, in the 30-day time frame, Biohaven Ltd (NYSE:BHVN) is -5.74% down. Looking at the short shares, we see there were 10.88 million shares sold at short interest cover period of 4.58 days.
The consensus price target for the stock as assigned by Wall Street analysts is 58.5, meaning bulls need an upside of 76.14% from its current market value. According to analyst projections, BHVN’s forecast low is 57 with 60 as the target high. To hit the forecast high, the stock’s price needs a -329.8% plunge from its current level, while the stock would need to soar -308.31% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -49.78%. The 2025 estimates are for Biohaven Ltd earnings to increase by 16.89%, but the outlook for the next 5-year period is at 17.95% per year.
BHVN Dividends
Biohaven Ltd is expected to release its next quarterly earnings report on 2025-May-12.
Biohaven Ltd (NYSE:BHVN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.96% of Biohaven Ltd shares while 90.75% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 103.08%. There are 90.75% institutions holding the Biohaven Ltd stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 8.2855% of the shares, roughly 7.27 million BHVN shares worth $252.41 million.
STIFEL FINANCIAL CORP holds the second largest percentage of outstanding shares, with 7.3839% or 6.48 million shares worth $224.94 million as of 2024-06-30.
